Lista de obras -

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

artículo científico publicado en 2017

Antipsychotic polypharmacy in a regional health service: a population-based study.

artículo científico publicado en 2012

Call for Action: Benzodiazepine Prescription Prevalence Analysis Shows Off-Label Prescription in One in Eleven Citizens

scientific article published on 06 September 2019

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

artículo científico publicado en 2014

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

artículo científico publicado en 2010

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

artículo científico publicado en 2013

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

artículo científico publicado en 2014

Detection of drug-drug interactions in prescription between levels of health care in human immunodeficiency virus-infected patients

artículo científico publicado en 2013

Different initiatives across Europe to enhance losartan utilization post generics: impact and implications

artículo científico publicado en 2014

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

article

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

artículo científico publicado en 2016

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

artículo científico publicado en 2014

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

artículo científico publicado en 2016

Personalizing health care: feasibility and future implications

artículo científico publicado en 2013

Policies to enhance prescribing efficiency in europe: findings and future implications

artículo científico publicado en 2010

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

artículo científico publicado en 2009

Social determinants of prescribed and non-prescribed medicine use

artículo científico publicado en 2010

The impact of new drug introduction on drug expenditure in primary health care in Catalunya, Spain

scientific article published on 30 November 2004

Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab

scientific article published on 01 February 2020

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

artículo científico publicado en 2010

[Performance assessment of health services in Catalonia (Spain): evaluation of initial results of the Catalan healthcare service project].

artículo científico publicado en 2009

Lista de obras de

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

Antipsychotic polypharmacy in a regional health service: a population-based study.

Call for Action: Benzodiazepine Prescription Prevalence Analysis Shows Off-Label Prescription in One in Eleven Citizens

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

Detection of drug-drug interactions in prescription between levels of health care in human immunodeficiency virus-infected patients

Different initiatives across Europe to enhance losartan utilization post generics: impact and implications

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

Personalizing health care: feasibility and future implications

Policies to enhance prescribing efficiency in europe: findings and future implications

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

Social determinants of prescribed and non-prescribed medicine use

The impact of new drug introduction on drug expenditure in primary health care in Catalunya, Spain

Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

[Performance assessment of health services in Catalonia (Spain): evaluation of initial results of the Catalan healthcare service project].